318 related articles for article (PubMed ID: 1422665)
1. Efficacy of low-dose iodine-131 ablation of post-operative thyroid remnants: a study of 69 cases.
Leung SF; Law MW; Ho SK
Br J Radiol; 1992 Oct; 65(778):905-9. PubMed ID: 1422665
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients.
Ramanna L; Waxman AD; Brachman MB; Tanasescu DE; Sensel N; Braunstein GD
Clin Nucl Med; 1985 Nov; 10(11):791-5. PubMed ID: 4075672
[TBL] [Abstract][Full Text] [Related]
3. Comparison of outcomes after (123)I versus (131)I pre-ablation imaging before radioiodine ablation in differentiated thyroid carcinoma.
Silberstein EB
J Nucl Med; 2007 Jul; 48(7):1043-6. PubMed ID: 17574976
[TBL] [Abstract][Full Text] [Related]
4. Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma.
Muratet JP; Daver A; Minier JF; Larra F
J Nucl Med; 1998 Sep; 39(9):1546-50. PubMed ID: 9744340
[TBL] [Abstract][Full Text] [Related]
5. Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinoma.
Muratet JP; Giraud P; Daver A; Minier JF; Gamelin E; Larra F
J Nucl Med; 1997 Sep; 38(9):1362-8. PubMed ID: 9293788
[TBL] [Abstract][Full Text] [Related]
6. Radioiodine therapy for differentiated thyroid carcinoma.
Connor CS; Thomas JH; Robinson RG; Preston DF; Hermreck AS
Am J Surg; 1988 Dec; 156(6):519-21. PubMed ID: 3202264
[TBL] [Abstract][Full Text] [Related]
7. Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: a randomized clinical trial in 509 patients.
Bal CS; Kumar A; Pant GS
J Clin Endocrinol Metab; 2004 Apr; 89(4):1666-73. PubMed ID: 15070929
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the efficacy of iodine-131 for thyroid ablation.
Comtois R; Thériault C; Del Vecchio P
J Nucl Med; 1993 Nov; 34(11):1927-30. PubMed ID: 8229236
[TBL] [Abstract][Full Text] [Related]
9. Thyroid remnant ablation in patients with papillary cancer: a comparison of low, moderate, and high activities of radioiodine.
Kusacic Kuna S; Samardzic T; Tesic V; Medvedec M; Kuna K; Bracic I; Despot M; Dodig D
Nucl Med Commun; 2009 Apr; 30(4):263-9. PubMed ID: 19247212
[TBL] [Abstract][Full Text] [Related]
10. Radioiodine-131 therapy for well-differentiated thyroid cancer--a quantitative radiation dosimetric approach: outcome and validation in 85 patients.
Maxon HR; Englaro EE; Thomas SR; Hertzberg VS; Hinnefeld JD; Chen LS; Smith H; Cummings D; Aden MD
J Nucl Med; 1992 Jun; 33(6):1132-6. PubMed ID: 1597728
[TBL] [Abstract][Full Text] [Related]
11. Superiority of iodine-123 compared with iodine-131 scanning for thyroid remnants in patients with differentiated thyroid cancer.
Mandel SJ; Shankar LK; Benard F; Yamamoto A; Alavi A
Clin Nucl Med; 2001 Jan; 26(1):6-9. PubMed ID: 11139058
[TBL] [Abstract][Full Text] [Related]
12. Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal.
Elisei R; Schlumberger M; Driedger A; Reiners C; Kloos RT; Sherman SI; Haugen B; Corone C; Molinaro E; Grasso L; Leboulleux S; Rachinsky I; Luster M; Lassmann M; Busaidy NL; Wahl RL; Pacini F; Cho SY; Magner J; Pinchera A; Ladenson PW
J Clin Endocrinol Metab; 2009 Nov; 94(11):4171-9. PubMed ID: 19850694
[TBL] [Abstract][Full Text] [Related]
13. Effects of low-iodide diet on postsurgical radioiodide ablation therapy in patients with differentiated thyroid carcinoma.
Pluijmen MJ; Eustatia-Rutten C; Goslings BM; Stokkel MP; Arias AM; Diamant M; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2003 Apr; 58(4):428-35. PubMed ID: 12641625
[TBL] [Abstract][Full Text] [Related]
14. The use of radioactive iodine in thyroid carcinoma.
Goolden AW
Eur J Cancer Clin Oncol; 1988 Feb; 24(2):339-43. PubMed ID: 3281849
[TBL] [Abstract][Full Text] [Related]
15. The significance of 1-131 scan dose in patients with thyroid cancer: determination of ablation: concise communication.
Waxman A; Ramanna L; Chapman N; Chapman D; Brachman M; Tanasescu D; Berman D; Catz B; Braunstein G
J Nucl Med; 1981 Oct; 22(10):861-5. PubMed ID: 7288483
[TBL] [Abstract][Full Text] [Related]
16. A randomized clinical trial comparing 50mCi and 100mCi of iodine-131 for ablation of differentiated thyroid cancers.
Zaman Mu; Toor R; Kamal S; Maqbool M; Habib S; Niaz K
J Pak Med Assoc; 2006 Aug; 56(8):353-6. PubMed ID: 16967785
[TBL] [Abstract][Full Text] [Related]
17. Radioiodine therapy for papillary and follicular thyroid carcinoma.
Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
[TBL] [Abstract][Full Text] [Related]
18. [Early evaluation of treatment effectiveness using 131I iodine radiotherapy in patients with differentiated thyroid cancer].
Gawkowska-Suwińska M; Turska M; Roskosz J; Puch Z; Jurecka-Tuleja B; Handkiewicz-Junak D; Wygoda Z; Jarzab B
Wiad Lek; 2001; 54 Suppl 1():278-88. PubMed ID: 12182036
[TBL] [Abstract][Full Text] [Related]
19. Post-operative diagnosis and therapy of thyroid carcinoma by nuclear medicine.
Hundeshagen H
Eur J Nucl Med; 1983; 8(12):541-5. PubMed ID: 6667704
[No Abstract] [Full Text] [Related]
20. Exercise-induced radio-iodine accumulation in scalp and hair during admission of 131I therapy for thyroid cancer.
Zakavi SR; Kakhki VD
Thyroid; 2006 Nov; 16(11):1185-6. PubMed ID: 17123349
[No Abstract] [Full Text] [Related]
[Next] [New Search]
